Company profile for M6P Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

M6P Therapeutics is a privately held, venture-backed life sciences company developing first-in-class, next-generation, targeted recombinant enzyme and gene therapies for lysosomal storage disorders (LSDs) by unlocking the potential of mannose 6-phosphate (M6P). Our first-in-class bicistronic-S1S3 technology platform enhances M6P content on lysosomal enzymes for both recombinant enzyme and gene therapies, which improves enzyme ...
M6P Therapeutics is a privately held, venture-backed life sciences company developing first-in-class, next-generation, targeted recombinant enzyme and gene therapies for lysosomal storage disorders (LSDs) by unlocking the potential of mannose 6-phosphate (M6P). Our first-in-class bicistronic-S1S3 technology platform enhances M6P content on lysosomal enzymes for both recombinant enzyme and gene therapies, which improves enzyme uptake across target tissues, allowing us to restore the enzymatic activity within this natural pathway.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
20 S. Sarah Street St. Louis, MO 63108
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

Global ChemShow

Not Confirmed

envelop Contact Supplier

Global ChemShow

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/04/09/3058338/0/en/M6P-Therapeutics-to-Host-Virtual-KOL-Event-to-Discuss-the-Lysosomal-Storage-Disorders-Treatment-Landscape-on-April-22-2025.html

GLOBENEWSWIRE
09 Apr 2025

https://www.globenewswire.com/news-release/2023/02/21/2612084/0/en/M6P-Therapeutics-Presents-Promising-Preclinical-Data-In-Lysosomal-Storage-Disorders-At-The-19th-Annual-WORLDSymposium-2023.html

GLOBENEWSWIRE
21 Feb 2023

https://www.businesswire.com/news/home/20220210006080/en

BUSINESSWIRE
11 Feb 2022

https://www.businesswire.com/news/home/20220201005998/en

BUSINESSWIRE
02 Feb 2022
M6P Therapeutics Presented Data on M041
M6P Therapeutics Presented Data on M041

29 Jul 2021

// BUSINESSWIRE

https://www.businesswire.com/news/home/20210728005496/en

BUSINESSWIRE
29 Jul 2021

https://www.businesswire.com/news/home/20210721005141/en

BUSINESSWIRE
21 Jul 2021

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty